🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢the program for #NCII 2025 #conference in #immunology (incl. #Inflammasome, #TLR, #cancer, #macrophage, #microbiota) is now online - check it out at innate-immunity-conference.de! Make sure to submit #abstracts to compete for oral talk slots and great prizes🥇

Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence a... sciencedirect.com/science/articl…

AutoAbs neutralizing IFN-Is exacerbate severe viral diseases. Groen et al. Ben Hale University of Zurich identify IFN-I regions commonly targeted by these autoAbs and develop a proof-of-concept decoy strategy to alleviate pathogenic effects. hubs.la/Q03cMHp90

Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design doi.org/10.1084/jem.20… rupress.org/jem/article/22…

An immune system defect makes affected individuals vulnerable to severe viral diseases such as influenza or COVID-19. It is caused by the body's own antibodies. UZH researchers have now generated “decoy molecules” that restore the immune defense – the foundation for a possible

Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design. New study from Kevin Groen, Benjamin Hale (Ben Hale) and colleagues University of Zurich: hubs.la/Q03cMv_Y0 #Autoimmunity #Immunodeficiency #InfectiousDisease

Real-life and in vitro evaluation of the antimicrobial effectiveness of a polycationic fabric coating pubmed.ncbi.nlm.nih.gov/40216192/

Great talk by Laura Brülisauer at #ESCMIDGlobal2025 - microcosms to study polymicrobial interactions in the nasal microbiota

Mycobacteria beyond disease sciencedirect.com/science/articl…

Mycobacteria beyond disease sciencedirect.com/science/articl…

Thrilled to share the preprint from my main postdoc project with Simon Heilbronner and Controlling Microbes to Fight Infections ! 🎉 We found that tyrosine availability can shape Staphylococcus aureus colonization in the nose by mediating its interactions with commensal species 🦠 biorxiv.org/content/10.110…

Decline of antimicrobial resistance in Pseudomonas aeruginosa bacteraemia following the COVID-19 pandemic: a longitudinal observational study academic.oup.com/jac/article/do…

Introducing CNS PCR panels does not automatically lead to shorter empiric antibiotic / antiviral treatment durations. We investigated the effect, and emphasize the need to educate prescribers on negative predictive values of tests to generate trust. academic.oup.com/ofid/article/1…

Dupilumab Treatment Is Associated With Clinical Improvement and a Shift Toward a Health-Associated Nasal Passage Microbiota in Diffuse Type 2 Chronic Rhinosinusitis ⁦Allergy EAACI⁩ ⁦Unispital_USZ⁩ ⁦⁦University of Zurich⁩ ⁦Insel Gruppe⁩ doi.org/10.1111/all.16…

Congrats to ⁦Pascal Frey⁩ for a SGAIM grant

Another #BTS look of #ESCMIDGlobal: Day 2 of the ESCMID Global Programme Committee meeting. Today is about fine-tuning content, addressing topical gaps, and of course, more brainstorming so that we can bring you the best possible programme for #ESCMIDGlobal2026! 🧠🦠🔬🤩

Annelies Zinkernagel impresses on the importance of building good communication skills to create great leaders in the field of infection. Communication in medicine has never been more important than it is now! youtube.com/watch?v=70u6UD…

Open Access: Dupilumab Treatment Is Associated With Clinical Improvement and a Shift Toward a Health-Associated Nasal Passage Microbiota in Diffuse Type 2 Chronic Rhinosinusitis. First author: Fabio S. Ryser; corresponding author: Silvio D. Brugger Read the article here:

📣 Launching ESCMID Media: the new ESCMID streaming platform 🚀 Offering a more intuitive way to engage with past ESCMID content from our congresses, events and Study Group webinars. Learn more: escmid.org/escmid-media/